The WHO estimates that the rise of multi-resistant bacteria to antibiotics will be one of the main causes of disease in the coming years. This means that bacteria that cause common infections today may become serious or fatal, as they will not respond to standard treatment. The increased use of antibiotics as a result of the Sars-Cov-2 pandemic further aggravates this reality.

Copptech has generated solutions that have demonstrated a broad antimicrobial spectrum, has all the potential to benefit health protection and healthcare in the medical field, putting Copptech at the service of health promotion and wellness. One solution under development that we believe has great potential is the application of Copptech technology in advanced wound care dressings. Copptech aims to create a solution to reduce wound infections by reducing the use of antibiotics, thereby reducing antibacterial resistance and minimising recovery and treatment times.

Today, surgical site infections occur in 2-4% of patients and are still one of the leading causes of morbidity and mortality in patients. It is the leading cause of death in patients readmitted to hospital after surgery (Patient Safety Network, 2019). This situation is especially alarming in those territories with less access to health services and which do not meet minimum hygiene and infrastructure standards. With this in mind, we are very proud of the progress we have made with this dressing, which has already been shown to reduce post-hospital readmissions by 38% in a clinical study (Arendsen, 2020).

We are motivated and willing to continue this line of research and development in order to make this technology available to all.